Skip to content

News · Science & Innovation

Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy

Source: ScienceDaily

A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes. The surprising difference suggests that diabetes itself may be driving the risk, although researchers caution that the drugs' safety during…

This is a short summary of a report by a third-party publisher. Newsline Press did not produce the original reporting.

Read the full story at ScienceDaily

Original publisher: ScienceDaily

Spotted an error? Request a correction · Corrections Policy

Related stories